Dr. Paul Sax discusses the results of the PURPOSE 2 trial, which tested lenacapavir for HIV prevention, in
HIV and ID Observations.
In the latest HIV and ID Observations, Dr. Paul Sax talks about how the results of the PURPOSE 1 and 2 trials highlight one of the great joys of HIV medicine.
Do you want to be notified whenever Dr. Sax posts? Sign up to receive notifications by email by using the Follow Via Email box.
Want to see more from NEJM Journal Watch? Register here.